Sotac Pharmaceuticals Limited — Board Meeting, 29-10-2024: Outcome of Board Meeting

SOTAC Pharmaceuticals Limited reported its unaudited standalone and consolidated financial results for the half year ended September 30, 2024. Standalone revenue from operations reached ₹3,061.42 lakhs, while net profit for the period was ₹211.64 lakhs. The consolidated revenue stood at ₹5,259.47 lakhs, with a net profit of ₹191.25 lakhs. The Board approved the financial results during its meeting and a limited review was conducted by statutory auditors.